Article By:
KKD Healthcare Analytics
Tuesday, September 5, 2017 11:32 AM EDT
Oramed Pharmaceuticals reported the successful conclusion of its meeting with the FDA with regard to its drug candidate ORMD-0801. Insmed (INSM) stock jumped over 100 percent in the pre-market session.